These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 32770187)

  • 1. Serum levels of galectin-3 in idiopathic inflammatory myopathies: a potential biomarker of disease activity.
    Watanabe E; Kato K; Gono T; Chiba E; Terai C; Kotake S
    Rheumatology (Oxford); 2021 Jan; 60(1):322-332. PubMed ID: 32770187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis.
    Vojinovic T; Cavazzana I; Ceruti P; Fredi M; Modina D; Berlendis M; Franceschini F
    Clin Rev Allergy Immunol; 2021 Feb; 60(1):87-94. PubMed ID: 33141387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease.
    Wang Y; Chen S; Lin J; Xie X; Hu S; Lin Q; Zheng K; Du G; Huang X; Zhang G; Gargani L; Matucci-Cerinic M; Furst DE
    Rheumatology (Oxford); 2020 Aug; 59(8):2024-2029. PubMed ID: 31794028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassay.
    Jee AS; Parker MJS; Bleasel JF; Troy LK; Lau EM; Jo HE; Teoh AKY; Webster S; Adelstein S; Corte TJ
    Respir Med; 2021 Oct; 187():106581. PubMed ID: 34454312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hsa-miR-7 Is a Potential Biomarker for Idiopathic Inflammatory Myopathies with Interstitial Lung Disease in Humans.
    Yu L; Li J; Chen Y; Jiang J; Fang Q; Jiang J; Wang D; Liu M
    Ann Clin Lab Sci; 2018 Nov; 48(6):764-769. PubMed ID: 30610047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.
    Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S
    Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort.
    Zanatta E; Cocconcelli E; Castelli G; Giraudo C; Fraia AS; De Zorzi E; Gatto M; Ienna L; Treppo E; Malandrino D; Cereser L; Emmi G; Giannelli F; Bellani S; Martini A; Moccaldi B; Ghirardello A; Avouac J; Quartuccio L; Allanore Y; Doria A; Spagnolo P; Balestro E; Iaccarino L
    RMD Open; 2023 Aug; 9(3):. PubMed ID: 37541742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of anti-Ro-52 antibodies with occurrence of interstitial lung disease in patients with idiopathic inflammatory myopathy.
    Weng CT; Huang TH; Wu CH; Sun YT
    Arthritis Res Ther; 2024 Aug; 26(1):152. PubMed ID: 39175076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple values of
    Li Y; Zhou Y; Wang Q
    Clin Rheumatol; 2017 Oct; 36(10):2297-2305. PubMed ID: 28831580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of natural killer cell depletion in predicting progressive fibrosing interstitial lung disease in idiopathic inflammatory myopathies.
    Shao C; Xia N; Zhen Y; Zhang X; Yan N; Guo Q
    Front Immunol; 2024; 15():1404828. PubMed ID: 38745647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human epididymis protein 4 as a clinical biomarker in identifying interstitial lung disease in patients with idiopathic inflammatory myopathies.
    Sun F; Zhao J; Li Y; Wang H; Cao X; Cheng W; Chen J
    Int Immunopharmacol; 2023 Feb; 115():109609. PubMed ID: 36577160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum ferritin as a significant biomarker for patients with idiopathic inflammatory myopathy-associated interstitial lung disease: A systematic review and meta-analysis.
    He X; Ji J; Chen X; Luo Z; Fang S; Yan H; Guo L
    Semin Arthritis Rheum; 2024 Feb; 64():152350. PubMed ID: 38086199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum KL-6 is associated with the severity of interstitial lung disease in Chinese patients with polymyositis and dermatomyositis.
    Hu C; Wu C; Yang E; Huang H; Xu D; Hou Y; Zhao J; Li M; Xu Z; Zeng X; Wang Q
    Clin Rheumatol; 2019 Aug; 38(8):2181-2187. PubMed ID: 30888566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatomyositis and Polymyositis in the Intensive Care Unit: A Single-Center Retrospective Cohort Study of 102 Patients.
    Peng JM; Du B; Wang Q; Weng L; Hu XY; Wu CY; Shi Y
    PLoS One; 2016; 11(4):e0154441. PubMed ID: 27115138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease.
    Richards TJ; Eggebeen A; Gibson K; Yousem S; Fuhrman C; Gochuico BR; Fertig N; Oddis CV; Kaminski N; Rosas IO; Ascherman DP
    Arthritis Rheum; 2009 Jul; 60(7):2183-92. PubMed ID: 19565490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myositis-Related Interstitial Lung Disease: A Respiratory Physician's Point of View.
    Waseda Y
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34200737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galactin-1, 3 and 9: Potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases.
    d'Alessandro M; De Vita E; Bergantini L; Mazzei MA; di Valvasone S; Bonizzoli M; Peris A; Sestini P; Bargagli E; Bennett D
    Respir Physiol Neurobiol; 2020 Nov; 282():103546. PubMed ID: 32920057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pirfenidone mitigates TGF-β1-mediated fibrosis in an idiopathic inflammatory myositis-associated interstitial lung disease model.
    Layoun H; Hajal J; Saliba Y; Smayra V; Habr B; Fares N
    Cytokine; 2022 Jun; 154():155899. PubMed ID: 35504143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of myositis autoantibodies in idiopathic inflammatory myopathy concomitant with interstitial lung disease.
    Huang HL; Lin WC; Lin PY; Weng MY; Sun YT
    Neurol Sci; 2021 Jul; 42(7):2855-2864. PubMed ID: 33211209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multidisciplinary Evaluation Helps Identify the Antisynthetase Syndrome in Patients Presenting as Idiopathic Interstitial Pneumonia.
    Chartrand S; Swigris JJ; Peykova L; Chung J; Fischer A
    J Rheumatol; 2016 May; 43(5):887-92. PubMed ID: 26932342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.